Camila Canaán-Haden | Biomedical research | Best Researcher Award

Posted on by ScienceFather

Ms. Camila Canaán-Haden | Biomedical research | Best Researcher Award

PhD student, Center for Genetic Engineering and Biotechnology (CIGB)

Camila Canaán-Haden Ayala is a Cuban researcher specializing in cancer immunotherapy. She works at the Center for Genetic Engineering and Biotechnology (CIGB), focusing on developing therapeutic cancer vaccines and recombinant antigen production. Her expertise includes immune response evaluations using ELISA, FACS, ELISPOT, and cytokine assays in various models. She has contributed to COVID-19 clinical trials and vaccine development, including the Abdala vaccine. Camila has undertaken multiple international research fellowships in Italy, Spain, France, and Mexico. Her work aims to improve immunotherapeutic strategies against cancer by targeting immune checkpoints and optimizing vaccine efficacy.

Profile

Scholar

🎓 Education

Camila holds a Master’s in Contemporary Biotechnology (2019-2022) from CIGB and a Bachelor’s in Biochemistry and Molecular Biology (2012-2017) from the University of Havana. She completed postgraduate training in bioinformatics, immunology, protein engineering, and good laboratory practices. Her academic foundation includes mathematics, chemistry, molecular genetics, virology, and clinical biochemistry. She has pursued advanced studies in biomedical research through multiple international pre-doctoral fellowships.

💼 Experience

Since 2017, Camila has been a researcher at CIGB’s Cancer Immunotherapy Lab. She has led projects on immune checkpoint inhibition strategies and therapeutic cancer vaccine development. Her work includes antigen cloning, protein characterization, and immunogenicity studies in animal models. She has evaluated antitumor and anti-metastatic effects of novel therapies and contributed to clinical trials for COVID-19 treatments. She has also worked with antibody phage display libraries to develop scFv antibodies. Her research extends to immune response assessments for cancer and infectious disease vaccines.

🏆 Awards & Honors

Camila has received prestigious short-term pre-doctoral fellowships in Italy (ICGEB-Trieste, University of Padua), Spain (CIBIR), France (Cancer Research Center of Lyon), and Mexico (CICESE), funded by international programs like IILA, Coimbra Group, and EU Ventana Adelante. Her contributions to COVID-19 vaccine research have been recognized in published scientific papers. She has played a key role in Cuban clinical trials for novel immunotherapies and has received funding for advanced research in biotechnology and immunology.

🔍 Research Focus

Camila’s research centers on cancer immunotherapy, focusing on immune checkpoint inhibition and tumor vaccine development. She specializes in recombinant antigen production, immune response characterization, and antibody-based therapies. Her projects involve antigen cloning, protein engineering, and evaluating vaccine efficacy in preclinical models. She has explored the combination of immunotherapies targeting VEGF and PD-L1 pathways to enhance anti-tumor responses. Her work has also contributed to COVID-19 vaccine research, particularly in evaluating immunogenicity and antibody responses.

Conclusion

Camila Canaán-Haden Ayala’s academic and professional trajectory is exceptional, with significant contributions to cancer immunotherapy and vaccine development. Her technical expertise, international exposure, and scientific output make her a strong contender for the Best Researcher Award. With a continued focus on expanding her clinical research impact, publishing in high-impact journals, and taking on leadership roles, her potential to drive groundbreaking innovations is evident.

Publication

M Limonta-Fernández, G Chinea-Santiago, AM Martín-Dunn, …
Title: An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
Year: 2022
Citation: 63

LA Espinosa, Y Ramos, I Andújar, EO Torres, G Cabrera, A Martín, …
Title: In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2
Year: 2021
Citation: 15

YA Fleites, J Aguiar, Z Cinza, M Bequet, E Marrero, M Vizcaíno, I Esquivel, …
Title: HeberNasvac, a therapeutic vaccine for chronic hepatitis B, stimulates local and systemic markers of innate immunity: Potential use in SARS-CoV-2 postexposure prophylaxis
Year: 2021
Citation: 10

LA Espinosa, Y Ramos, I Andújar, EO Torres, G Cabrera, A Martín, …
Title: In-solution buffer-free digestion for the analysis of SARS-CoV-2 RBD proteins allows a full sequence coverage and detection of post-translational modifications in a single ESI
Year: 2021
Citation: 8

Y Morera-Díaz, C Canaán-Haden, J Sánchez-Ramírez, …
Title: Active immunization with a structurally aggregated PD-L1 antigen breaks T and B immune tolerance in non-human primates and exhibits in vivo anti-tumoral effects in
Year: 2023
Citation: 4

D Vázquez-Blomquist, M Bequet-Romero, Y Mendoza-Marí, G Lemos, …
Title: Nasalferon, a new nasal formulation of IFNα2b, modulates cellular and molecular elements associated with an antiviral response in mucosa and blood
Year: 2022
Citation: 4

EM Idelsis, PE Jésus, DR Yaquelin, VB Dania, BR Mónica, BR Lisandra, …
Title: A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trial
Year: 2021
Citation: 4

C Canaán-Haden, J Sánchez-Ramírez, R Martínez-Castillo, …
Title: Immunogenicity and Safety Profile of Two Adjuvanted-PD-L1-Based Vaccine Candidates in Mice, Rats, Rabbits, and Cynomolgus Monkeys
Year: 2025
Citation: N/A

Y Morera, M Bequet-Romero, F Hernández-Bernal, I González-Moya, …
Title: Preclinical and clinical significance of VEGF deprivation in ovarian cancer through a specific active immunotherapy
Year: 2023
Citation: N/A

Neeraj Kumar Pandey | Pharmaceutical Sciences | Young Scientist Award

Posted on by ScienceFather

Mr. Neeraj Kumar Pandey | Pharmaceutical Sciences | Young Scientist Award

Guru kashi university, India

Neeraj Kumar Pandey is a dedicated pharmacist from Singahi, Sahatwar, Ballia, India, with a strong passion for healthcare and pharmaceutical sciences. He holds a Diploma in Pharmacy from Guru Kashi University, where he excelled academically. With hands-on experience in hospital training and roles as a campus ambassador, NSS volunteer, and journal reviewer, he actively contributes to the healthcare sector. Neeraj has published multiple books and research articles, highlighting his expertise in pharmaceutical education. His skills include pharmaceutical dispensing, patient counseling, and content development. He has received several awards, including the International Icon Award 2024.

 

Publication Profile

Orcid

🎓 Education

Neeraj Kumar Pandey completed his high school and intermediate education under the UP Board with outstanding scores. He pursued a Diploma in Pharmacy from Guru Kashi University, achieving top marks in both years. Additionally, he completed software development training, enhancing his technical proficiency. His academic journey reflects his commitment to excellence in pharmaceutical sciences.

💼 Experience

Neeraj has gained practical experience through hospital training at SDH Talwandi Sabo and worked as Nikshay Mitra, contributing to tuberculosis eradication. He serves as a campus ambassador for PW Skills & MyGov and is an active NSS volunteer. Additionally, he reviews research articles for UGC Care List Journals, demonstrating his engagement with academic and professional communities. His diverse experience strengthens his expertise in pharmacy and healthcare.

🏆 Awards & Honors

Neeraj has been recognized with multiple prestigious awards, including the SBI Student of the Year Award 2013, Certificate of Merit, Award of Appreciation, Award of Excellence, and the International Icon Award 2024. His achievements highlight his dedication to academic excellence and contributions to healthcare and research. These accolades reflect his commitment to professional growth and leadership in the pharmaceutical sector.

🔬 Research Focus

Neeraj’s research interests span various pharmaceutical fields, including drug dispensing, patient care, and psychopharmacology. His publications cover topics such as psychosomatic disorders and erectile dysfunction in young men. He has also authored books on pharmaceutical chemistry, human anatomy, and medical ethics, emphasizing his deep engagement with research and education. His work aims to bridge knowledge gaps in pharmacy and healthcare.

Publication Top Notes

  • Mind Body Nexus: Bridging Gaps in Psychosomatic Disorders Treatment and Assessment for Holistic Care
    Goya Journal, 2024-02-24 | Journal article
    Contributors: Neeraj Kumar Pandey, Devinder Maheswary

 

  • Cognite: Pharmaceutical Chemistry
    Notion Press Media Pvt. Ltd., 2024-02-02 | Book
    Contributors: Neeraj Kumar Pandey, Inderjeet Kaur

 

  • Atharva: A Medicinal Plants Handbook
    Notion Press Media Pvt. Ltd., 2024-01-19 | Book
    Contributors: Neeraj Kumar Pandey, S. Pargat Singh

 

  • Pharmaceutical Practical Handbook
    Notion Press Media Pvt. Ltd., 2024-01-10 | Book
    Contributors: Neeraj Kumar Pandey, Dr. Devinder Kumar Maheshwari

 

Ensiyeh Jenabi | Medicine| Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Ensiyeh Jenabi | Medicine| Best Researcher Award

Assistant Professor, Hamadan University of Medical Sciences, Iran

Ensiyeh Jenabi is an Iranian researcher and academic in midwifery, specializing in reproductive health. With a B.Sc. and M.Sc. in Midwifery from Hamadan and Tabriz Universities, respectively, she earned her Ph.D. in Reproductive Health from Hamadan University of Medical Sciences. Dr. Jenabi currently serves as a faculty member, teaching research methods and menopause courses at both MSc and PhD levels since 2017. She is an active member of the Autism Spectrum Disorders Research Center and the Mother and Child Care Research Center at Hamadan University of Medical Sciences, contributing to advancements in women’s health. 🌍💡

Publication Profile

Google Scholar

🎓 Education

B.Sc. in Midwifery, Hamadan University of Medical Sciences 🇮🇷. M.Sc. in Midwifery, Tabriz University of Medical Sciences 🇮🇷. Ph.D. in Reproductive Health, Hamadan University of Medical Sciences

💼 Experience

Faculty Member, Hamadan University of Medical Sciences, since 2017 . Researcher, Autism Spectrum Disorders Research Center, since 2018.  Researcher, Mother and Child Care Research Center, since 2018 . Member, Research in Education Committee at EDC, Hamadan University, since 2018 .

🏆 Awards & Honors

Recognized for outstanding research contributions in reproductive health.  Awarded various academic grants for research on women’s health.  Honored as a prominent reviewer for prestigious health journals .

🔬 Research Focus

Dr. Jenabi’s research primarily focuses on reproductive health, menopause, maternal and child care, and autism spectrum disorders. She is dedicated to advancing evidence-based practices in midwifery and women’s health through her ongoing studies and collaborations.

Conclusion

Ensiyeh Jenabi stands out as an accomplished researcher in reproductive health, making substantial contributions to both teaching and research at the Hamadan University of Medical Sciences. Her work in the domains of maternal health, menopausal care, and autism spectrum disorders shows her dedication to improving public health. With continued efforts to expand her research network and collaboration, she is poised to make even greater strides in her field, making her a strong contender for the Best Researcher Award.

Publication Top Notes

  • Factors associated with in-hospital death in patients with nosocomial infections: a registry-based study using community data in western Iran
    • Year: 2020
    • Authors: S Khazaei, E Ayubi, E Jenabi, S Bashirian, M Shojaeian, L Tapak
    • Citation: 11
  • Placenta previa after prior abortion: a meta-analysis
    • Year: 2017
    • Authors: M Karami, E Jenabi
    • Citation: 11
  • The association between hot flushes and smoking in midlife women: a meta-analysis
    • Year: 2015
    • Authors: E Jenabi, J Poorolajal
    • Citation: 11
  • The environmental risk factors associated with ectopic pregnancy: An umbrella review
    • Year: 2023
    • Authors: E Jenabi, E Ayubi, S Khazaei, AR Soltanian, AM Salehi
    • Citation: 9
  • COVID-19 prevention behaviors among health staff: data from a large survey in the west of Iran
    • Year: 2021
    • Authors: S Bashirian, S Khazaei, M Barati, E Jenabi, AR Soltanian, S Shirahmadi, …
    • Citation: 9
  • Etiology and outcome of burns in Hamadan, Iran: a registry-based study
    • Year: 2019
    • Authors: S Khazaei, F Shirani, M Afshari, E Jenabi, Z Hamzei, M Torabi, T Bathaei
    • Citation: 9
  • Maternal Smoking and the Risk of Placenta Accreta Spectrum: A Systematic Review and Meta‐Analysis
    • Year: 2022
    • Authors: E Jenabi, AM Salehi, SZ Masoumi, A Maleki
    • Citation: 8
  • Reinforcement and Maintenance of Human Resources for Health Systems during Long‐Term Crises: A Systematic Review of Systematic Reviews
    • Year: 2021
    • Authors: AM Salehi, S Khazaei, M Masumi, F Shavandi, M Kavand, E Jenabi, …
    • Citation: 8
  • Assessment of mask-wearing adherence and social distancing compliance in public passengers in Hamadan, Iran, during the COVID-19 pandemic
    • Year: 2021
    • Authors: AR Soltanian, T Omidi, S Khazaei, S Bashirian, R Heidarimoghadam, …
    • Citation: 8
  • Effect of Vitamin E on Reduction of Muscle Pain in Students with Premenstrual Syndrome
    • Year: 2014
    • Authors: F Shabiri, E Jenabi
    • Citation: 8

 

 

Leila mousavi | Health Professions | Best Researcher Award

Posted on by ScienceFather

Dr. Leila mousavi | Health Professions | Best Researcher Award

Dr at Tehran University,  Iran

Leila Mousavi is a specialist in pathology and corrective exercise, known for her perseverance in research and her dedication to helping individuals with scoliosis, both athletes and non-athletes. She combines scientific knowledge with practical experience in exercise therapy to assist in managing scoliosis deformities. Her commitment to research is evident in her numerous publications, focusing on postural control, balance, and sports performance, particularly in athletes with scoliosis. She has a track record of high-quality exercise regimens tailored to scoliosis patients, aiming to improve posture, strength, and overall well-being.

Profile

Scopus

Education 🎓

Leila Mousavi completed her Ph.D. in Pathology and Corrective Exercise at Tehran University in 2022. She earned her Master’s degree in Physical Education, specializing in Pathology and Corrective Exercise, from Guilan University in 2010. Additionally, she holds a Bachelor’s degree in Physical Education from Guilan University, completed in 2007. Her extensive educational background laid the foundation for her expertise in pathology, corrective exercise, and rehabilitation for scoliosis patients.

 Experience 💼

Leila Mousavi has over a decade of teaching and research experience. She served as a visiting professor at Zanjan University from 2011 to 2014, where she taught sports pathology, exercise therapy, and corrective exercises. She also worked at Payame Noor University of Zanjan, offering courses in sports pathology, kinesiology, anatomy, biomechanics, and more from 2010 to 2014. Her work combines academic teaching with practical applications in sports rehabilitation and exercise therapy for athletes and individuals with scoliosis.

Awards and Honors 🏆

Leila Mousavi has contributed significantly to the field of sports pathology and corrective exercise, with her research being widely recognized. She has published multiple impactful papers, including in journals such as iScience and BMJ Open Sport & Exercise Medicine. Mousavi is also a peer reviewer for PLOS One, contributing to the academic community. Her research work on scoliosis, posture control, and sports performance is widely cited, and she continues to advance the understanding of corrective exercises for scoliosis patients.

Research Focus 🔍

Leila Mousavi’s research primarily focuses on corrective exercise for scoliosis deformities, specifically in athletes. She is also involved in postural control, balance, and sports performance, with a special interest in idiopathic scoliosis and its impact on athletic performance. Her work includes systematic reviews and meta-analyses, with a focus on the prevalence of scoliosis in athletes and the biomechanics of posture control. Mousavi’s research aims to develop specific exercise regimens that improve postural control and reduce symptoms for scoliosis patients, enhancing both their daily lives and athletic performance.

Conclusion 📝

Dr. Leila Mousavi’s expertise and pioneering research in pathology, corrective exercise, and sports performance position her as an exceptional candidate for the Best Researcher Award. Her academic contributions, particularly in the realm of scoliosis, highlight her potential to further revolutionize the understanding and management of musculoskeletal conditions. With continued innovation and collaboration, she is poised to make even greater strides in improving patient care and athletic performance.

Publications 📚

    1. Postural control and shoulder rotators isokinetic strength in squash players with and without idiopathic scoliosis
      Authors: Mousavi L., Seidi F., Minoonejad H., Nikouei F.
      Journal: iScience, 2024
      DOI: 10.1016/j.isci.2024.111353
    1. Prevalence of idiopathic scoliosis in athletes: a systematic review and meta-analysis
      Authors: Mousavi L., Seidi F., Minoonejad H., Nikouei F.
      Journal: BMJ Open Sport & Exercise Medicine, 2022
      DOI: 10.1136/bmjsem-2022-001312

    Earlier Publications

    1. The comparison of muscle length and strength of lower extremity in athletes with and without patellofemoral pain syndrome
      Author: Mousavi L. S., Norasteh A. A.
      Journal: Medicina dello Sport, 2011, 64(3), 213-229
    1. The comparison of iliotibial band length and Q angle in athletes with and without patellofemoral pain syndrome
      Authors: Mousavi L., Norasteh A. A.
      Journal: 2010, 5, 115-131
    1. The effect of time of day on static and dynamic postural control in female and male athletes
      Authors: Mousavi L., Shahrokhi H., Norasteh A. A.
      Journal: 2009, 3, 113-127

 

 

 

Kyu Sik Kim| Medicine | Young Scientist Award

Posted on by ScienceFather

Mr. Kyu Sik Kim| Medicine | Young Scientist Award

Mr at Seoul National University, South Korea

Kyu Sik Kim is a dedicated PhD candidate at Seoul National University, specializing in systems neuroscience. His research focuses on how the hypothalamus regulates feeding behavior and seeks to bridge the gap between animal and human studies. Passionate about improving therapeutic outcomes, he aims to translate his findings into better treatment options.

 

Publication profile

Scopus

Orcid

Scholar

🎓 Education & Training

M.S./Ph.D. Candidate in Biomedical Science, Seoul National University, College of Medicine (2020–Present) Advisor: Prof. Hyung Jin Choi. B.S. in Life Science, Sogang University, Seoul, Korea (2014-2018)

🔬 Major Research Interests

Brain activity and ethology analysis with artificial intelligence. Internal state changes in the brain. Competing needs and motivation in the brain. Hypothalamic neuronal circuits in emotion and eating. Translational research and clinical applications

🏆 Honors, Funding & Awards

2024: 2-year research program (48M Won) for cultivating future generations in science and engineering. 2024: Basic Academic Field Academic Subsequent Generation (24M Won). 2024: Optodbs Travel Grant. Multiple prizes for Outstanding Graduate Student at Seoul National University (2023-2024). Best Paper Award (March-May 2023)

🛠 Skills & Professional Expertise

Software Tools: Ethovision, Inscopix Data Processing, MATLAB, Python. Experimental Techniques: Immunocytochemistry, stereotaxic surgery, animal behavior experiments, and fMRI imaging. Teaching & Mentoring: Guided students in medical research programs at Seoul National University

Publication

  • Lateral Hypothalamic Leptin Receptor Neurons Drive Hunger-Gated Food-Seeking and Consummatory Behaviours in Male Mice
    • Authors: Y.H. Lee, Y.B. Kim, K.S. Kim, M. Jang, H.Y. Song, S.H. Jung, D.S. Ha, J.S. Park, …
    • Published In: Nature Communications, 14(1), 1486
    • Citations: 19
    • Year: 2023

 

  • GLP-1 Increases Preingestive Satiation via Hypothalamic Circuits in Mice and Humans
    • Authors: K.S. Kim, J.S. Park, E. Hwang, M.J. Park, H.Y. Shin, Y.H. Lee, K.M. Kim, L. Gautron, …
    • Published In: Science, 385(6707), 438-446
    • Citations: 6
    • Year: 2024

 

  • Acoustic Deep Brain Modulation: Enhancing Neuronal Activation and Neurogenesis
    • Authors: H. Ham, K.S. Kim, J.H. Lee, D.N. Kim, H.J. Choi, J.J. Yoh
    • Published In: Brain Stimulation
    • Year: 2024

 

  • A Normative Framework Dissociates Need and Motivation in Hypothalamic Neurons
    • Authors: K.S. Kim, Y.H. Lee, Y.B. Kim, J.W. Yun, H.Y. Song, J.S. Park, S.H. Jung, J.W. Sohn, …
    • Published In: bioRxiv
    • Year: 2023

 

Haseeb Sattar | Clinical Medicine | Best Faculty Award

Posted on by ScienceFather

Assoc Prof Dr. Haseeb Sattar | Clinical Medicine  | Best Faculty Award

Assoc Prof Dr Haseeb Sattar Urban Vocational College of Sichuan Chengdu China

Dr. Haseeb Sattar is a seasoned medical professional with extensive experience in clinical pharmacotherapy and internal medicine. He holds a PhD in Clinical Pharmacology from Huazhong University of Science and Technology, China, and has served as an Assistant Professor at several prestigious universities in China, teaching clinical subjects to international MBBS students. Dr. Sattar has a strong background in research, with numerous publications in leading medical journals. His career is distinguished by his commitment to medical education, research, and patient care, making him a valuable asset to any academic or clinical institution.

Publication profile

Scopus

Scholar

🎓 Education

PhD/DM in Clinical Pharmacology-Clinical Pharmacy – Tongji Medical College of Huazhong University of Science and Technology, China. Dates: September 2014 – June 2017. PG-Dip in Internal Medicine – University of Edinburgh, UK Dates: September 2018 – August 2020. MPhil in Medical Microbiology – Quaid-i-Azam University, Islamabad, Pakistan Dates: January 2012 – 2014. Doctor of Pharmacy (PharmD) – Riphah International University, Islamabad, Pakistan Dates: September 2005 – August 2010. Higher Secondary School Certificate (HSSC) – Federal Board of Intermediate & Secondary Education, Islamabad, Pakistan. Dates: August 2002 – August 2004. Diploma in Computer Hardware – Super Tech Institute of Computer Sciences Dates: May 2002 – August 2002. Secondary School Certificate (SSC) – Federal Board of Intermediate & Secondary Education, Islamabad, Pakistan Dates: March 2000 – March 2002

👨‍🏫 Professional Experience

Assistant Professor of Medicine – Chengdu University of TCM, Chengdu, China Dates: September 2019 – Present Responsibilities: Teaching clinical subjects to foreign MBBS students. Assistant Professor of Medicine – Hubei University of Traditional Chinese Medicine, Wuhan, China Dates: September 2017 – July 2019 Responsibilities: Teaching clinical subjects to foreign MBBS students. Lecturer (Part-Time) – Hubei University of Nationality, Enshi, China Dates: July 2016 – July 2017. Responsibilities: Teaching internal medicine, diagnostics, pharmacology, preventive medicine, and infectious diseases. Lecturer of Clinical Pharmacotherapeutics and Clinical Practices – University of Lahore, Islamabad Campus Dates: September 2010 – September 2014 Responsibilities: Taking lectures, hospital ward rounds.

🏅 Certifications

American Board Certification in Pharmacotherapy (BCPS), USA. American Board-Certified Cardiology Specialist (BCCP). Certification in Toxicology, Harvard Medical University, USA. Certification in Endocrine Emergencies, Harvard Medical University, USA. Certification in COPD Management, University of Pennsylvania School of Medicine, USA

📝 Research Publications

Sattar, Haseeb, et al. “Role of glucuronidation pathway in quetiapine metabolism: An in vivo drug–drug interaction study between quetiapine and probenecid.” Saudi Journal of Medicine & Medical Sciences, 2020. Nie Q, Sattar H, et al. “An intramural left ventricular fistula caused by left ventriculography.” World Journal of Emergency Medicine, 2022. Luo Y, Jiang Q, Zhu Z, Sattar H, et al. “Phosphoproteomics and proteomics reveal metabolism as a key node in LPS-induced acute inflammation in RAW264. 7.” Inflammation, 2020.

🏆 Achievements

Recipient of the Chinese Government Scholarship. Multiple scholarships during university (Mumtaz Scholarships)

Evaluation for Best Faculty Award 🏆

Strengths for the Award:

Extensive Clinical and Academic Experience: Dr. Haseeb Sattar has over a decade of experience in clinical pharmacotherapy and internal medicine, with a strong foundation in both practical and theoretical aspects of the field. His roles in various academic institutions, particularly in teaching clinical subjects to MBBS students, demonstrate his commitment to education and student development. Diverse Educational Background: Dr. Sattar’s qualifications, including a Doctor of Pharmacy (PharmD), MPhil in Medical Microbiology, and PhD/DM in Clinical Pharmacology, provide him with a broad and in-depth understanding of medicine. His postgraduate diploma in Internal Medicine from the University of Edinburgh further solidifies his expertise. Research Accomplishments: With numerous publications in reputable journals, Dr. Sattar has contributed significantly to medical research. His work spans various topics, including pharmacotherapy, clinical pharmacy, and internal medicine, reflecting his active engagement in advancing medical knowledge. International Exposure: Dr. Sattar’s teaching and research experiences across Pakistan and China, coupled with certifications from prestigious institutions in the USA, highlight his global perspective and adaptability in different educational and healthcare environments. Recognition and Awards: Dr. Sattar has been the recipient of multiple scholarships, including the prestigious Chinese Government Scholarship, which underscores his academic excellence and recognition by international bodies.

Areas for Improvement:

Focused Research Themes: While Dr. Sattar has published extensively, focusing on a more specific research theme or developing a specialized niche could enhance his recognition in a particular area of medicine. Increased Collaboration: Engaging in more collaborative research with other international institutions and experts could further elevate his profile and contribute to broader scientific advancements. Leadership Roles: Taking on more leadership roles in academic or research institutions could showcase his ability to influence and guide future research directions and academic programs.

Publication top notes

  • Reactive Oxygen Species‐Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer
    • Journal: Oxidative Medicine and Cellular Longevity
    • Year: 2018
    • DOI: 10.1155/2018/5801209
    • Contributors: H. Gu, T. Huang, Y. Shen, Y. Liu, F. Zhou, Y. Jin, H. Sattar, Y. Wei
    • Citations: 64

 

  • Co-existence of blaNDM-1 and blaKPC-2 in Clinical Isolates of Klebsiella pneumoniae from Pakistan
    • Journal: Journal of Chemotherapy
    • Year: 2016
    • Volume: 28(4), 346-349
    • Contributors: H. Sattar, M. Toleman, F. Nahid, R. Zahra
    • Citations: 35

 

  • The Prognostic Value of Long Noncoding RNAs in Prostate Cancer: A Systematic Review and Meta-Analysis
    • Journal: Oncotarget
    • Year: 2017
    • Volume: 8(34), 57755
    • Contributors: W. Ma, X. Chen, L. Ding, J. Ma, W. Jing, T. Lan, H. Sattar, Y. Wei, F. Zhou
    • Citations: 24

 

  • Natural Killer Cell Immunotherapy Against Multiple Myeloma: Progress and Possibilities
    • Journal: Journal of Leukocyte Biology
    • Year: 2018
    • Volume: 103(5), 821-828
    • Contributors: P. Liu, Y. Jin, H. Sattar, H. Liu, W. Xie, F. Zhou
    • Citations: 18

 

Conclusion:

Dr. Haseeb Sattar’s extensive clinical experience, robust academic background, and significant research contributions make him a strong candidate for the Best Faculty Award. His diverse expertise and international exposure, combined with his dedication to education and research, position him as an exemplary figure in the field of medicine. With a focus on further specialization and increased collaborative efforts, Dr. Sattar’s impact on the medical community is likely to grow, making him well-deserving of this recognition.

Hao Chi | clinical medicine | Young Scientist Award

Posted on by ScienceFather

 Mr. Hao Chi |Electoral Studies | Best Researcher Award 

Dr. Hao Chi, MD, is affiliated with the Clinical Medical College at Southwest Medical University in Luzhou, China. With an H-index of 21 and 1069 citations, Dr. Chi is a prolific researcher focusing on programmed cell death, therapy resistance in cancers, immune microenvironment, advanced data analysis, and exosomal dynamics in tumor ecology. He has contributed to numerous high-impact journals and serves on editorial boards and as a guest editor for several scientific publications. Dr. Chi’s expertise in utilizing cutting-edge sequencing technologies and bioinformatics positions him at the forefront of cancer research and personalized medicine.

Profile

Scholar

Education 🎓

MD, Clinical Medicine
Southwest Medical University, Luzhou 646000, China

Research Experiences and Interests 🔬

Programmed Cell Death and Tumor Prognosis Investigating the mechanisms of programmed cell death and their relevance to tumor prognosis.
Publications: Frontiers in Genetics 2022, Cells 2022, Frontiers in Molecular Biosciences 2023. Molecular Mechanisms of Therapy Resistance of Cancers Studying genetic, epigenetic, and immune system factors leading to cancer cell resistance to treatments. Publications: Journal of Medical Virology 2023, Frontiers in Immunology 2023. Immune Microenvironment and Cancer Prognostication Analyzing the tumor immune microenvironment to identify prognostic markers. Publications: Frontiers in Immunology 2022, 2023. Advanced Data Analysis in Disease Applying machine learning to diagnose and prognose diseases using multi-omics data. Publications: Frontiers in Endocrinology 2022, Tumour Virus Research 2023, Frontiers in Oncology 2023. Single-Cell and High-Throughput Sequencing Technologies Utilizing sequencing technologies to explore tumor microenvironment and therapeutic responses. Publications: Frontiers in Immunology 2023, Frontiers in Molecular Biosciences 2023, Frontiers in Pharmacology 2023. Exosomal Dynamics in Tumor Ecology Investigating the role of exosomes in cancer progression and their therapeutic potential. Publications: Journal of Oncology 2022, Frontiers in Immunology 2022, 2023.

Skills 🛠️

  1. Data Analysis
    • Proficient in R language and bioinformatics for processing and visualizing patient data from TCGA, GEO, ICGC, and CGGA.
    • Integrating high-throughput sequencing data, single-cell sequencing data, and spatial transcriptome data.
  2. Cellular and Molecular Biology
    • Designing and performing cellular phenotyping experiments.
    • Cell culture and transfection.
    • Techniques: PCR, WB, IHC, transfection, MTT, Edu assay, CCK8, transwell assay, wound healing assay, colony formation assay, flow cytometry.
  3. Animal Experiments
    • In vivo experiments, including subcutaneous tumor formation, tumor tissue collection, and physiological monitoring.

Academic Positions 🧑‍🏫

  1. Editorial Board Member
    • Discover Immunity (2024)
    • BMC Cancer (2023-present)
    • Discover Oncology (2023-present)
    • iMeta (2023-present)
  2. Guest Editor
    • Discover Oncology (2024)
    • Current Protein & Peptide Science (2024)
    • Current Genomics (2024)
    • Frontiers in Immunology (2024)
    • Current Cancer Drug Targets (2024)
    • Current Gene Therapy (2024)
    • Journal of Visualized Experiments (2023)
  3. Editorial Review Board Member
    • Oncology Research (2024)
    • Technology in Cancer Research & Treatment (2024.02-present)
    • Cancer Control (2024.02-present)
  4. Reviewer
    Journals including International Journal of Surgery, European Journal of Internal Medicine, Cancer Letters, Cell Communication and Signaling, Computers in Biology and Medicine, iScience, Inflammation Research, Environmental Toxicology, Scientific Reports, Heliyon, Frontiers in Immunology, Aging, Discover Oncology, Journal of Gene Medicine, BMC Bioinformatics, BMC Medical Genomics, BMC Cancer, BMC Pulmonary Medicine, Functional & Integrative Genomics, Archives of Dermatological Research, Journal of Orthopaedic Surgery and Research, Molecular and Cellular Biochemistry, PLOS ONE, Current Pharmaceutical Design, Open Life Sciences, JOVE, Medicine, Frontiers in Pharmacology, Frontiers in Genetics, Frontiers in Oncology, Frontiers in Surgery, Frontiers in Aging Neuroscience, Frontiers in Neuroscience, Frontiers in Molecular Biosciences, Frontiers in Public Health, Gene, Journal of Cancer, Acta Oncologica, Journal of the COPD Foundation, Cell Biology International, Oncology Research, Artificial Intelligence in Medicine, Expert Opinion on Drug Safety, Pharmaceutical Biology, Experimental Cell Research, Current Drug Targets, Journal of Inflammation Research, Journal of Stroke and Cerebrovascular Diseases, iMeta, Turkish Journal of Gastroenterology, Pharmaceutical Biology, Journal of Pain Research, World Journal of Urology, International Journal of Molecular Medicine, Diabetes, Obesity and Metabolism, Annals of Medicine, Technology in Cancer Research & Treatment, Acta Psychologica, OncoTargets and Therapy.

Oral Presentations 🎤

Invited Speaker, “Guidance on University Students’ Innovation and Entrepreneurship Projects,” Scientific Research Department of Southwest Medical University, Luzhou, China, March 2023. Workshop Conductor, “Integrating High-Throughput Sequencing Data with Machine Learning,” Sino-German Laboratory at the Affiliated Hospital of Southwest Medical University, Luzhou, China, May 2023. Presenter, Summer Research Symposium, General Hospital of the People’s Liberation Army, “Integration of Modern Medicine with Acupuncture and Moxibustion Research,” Beijing, China, May 2023. Featured Speaker, Fall Research Symposium, Beijing University of Chinese Medicine, “Advances in Breast Cancer by Single Cell Sequencing,” Beijing, China, July 2023. Keynote Speaker, “Single-Cell Sequencing: Implications for Precision Medicine,” The Affiliated Hospital of Southwest Medical University, Luzhou, China, June 2023. Invited Speaker, “Multi-Omics and Machine Learning: A New Era in Disease Understanding,” Chongqing Biomarkers Committee, Chongqing, China, October 2023. Invited Speaker, “Macao University of Science and Technology (MUST) Faculty of Medicine Chinese Medicine Master Teachers Forum Meeting,” Macau University of Science and Technology, Macau, China, October 2023.

Book Publications 📚

  • Deputy Editor: Clinical Research on Chinese Medicine Treatment for Diabetes Mellitus, Shanghai Jiao Tong University Press, Shanghai, China, 2023.

Publications Top Notes 📝

  • Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
    • Authors: H. Chi, X. Xie, Y. Yan, G. Peng, D.F. Strohmer, G. Lai, S. Zhao, Z. Xia, G. Tian
    • Journal: Frontiers in Immunology, 2022
    • Citations: 79

 

  • A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration
    • Authors: H. Chi, P. Jiang, K. Xu, Y. Zhao, B. Song, G. Peng, B. He, X. Liu, Z. Xia, G. Tian
    • Journal: Frontiers in Genetics, 2022
    • Citations: 79

 

  • T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing
    • Authors: H. Chi, S. Zhao, J. Yang, X. Gao, G. Peng, J. Zhang, X. Xie, G. Song, K. Xu
    • Journal: Frontiers in Immunology, 2023
    • Citations: 63

 

  • Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson’s disease
    • Authors: S. Zhao, H. Chi, Q. Yang, S. Chen, C. Wu, G. Lai, K. Xu, K. Su, H. Luo, G. Peng
    • Journal: Frontiers in Immunology, 2023
    • Citations: 54

 

  • Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity
    • Authors: H. Chi, J. Yang, G. Peng, J. Zhang, G. Song, X. Xie, Z. Xia, J. Liu, G. Tian
    • Journal: Frontiers in Immunology, 2023
    • Citations: 5

 

  • Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer
    • Authors: S. Zhao, X. Zhang, F. Gao, H. Chi, J. Zhang, Z. Xia, C. Cheng, J. Liu
    • Journal: Frontiers in Endocrinology, 2023
    • Citations: 52

 

  • Cuprotosis programmed-cell-death-related lncRNA signature predicts prognosis and immune landscape in PAAD patients
    • Authors: H. Chi, G. Peng, R. Wang, F. Yang, X. Xie, J. Zhang, K. Xu, T. Gu, X. Yang
    • Journal: Cells, 2022
    • Citations: 47

 

  • IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
    • Authors: Y. Zhao, K. Wei, H. Chi, Z. Xia, X. Li
    • Journal: Frontiers in Immunology, 2022
    • Citations: 42

 

  • Exosomes: A potential tool for immunotherapy of ovarian cancer
    • Authors: X. Gong, H. Chi, D.F. Strohmer, A.T. Teichmann, Z. Xia, Q. Wang
    • Journal: Frontiers in Immunology, 2023
    • Citations: 40

 

  • A bioinformatics-based analysis of an anoikis-related gene signature predicts the prognosis of patients with low-grade gliomas
    • Authors: S. Zhao, H. Chi, W. Ji, Q. He, G. Lai, G. Peng, X. Zhao, C. Cheng
    • Journal: Brain Sciences, 2022
    • Citations: 40

 

Divya Kumar | Clinical |Best Researcher Award

Posted on by ScienceFather

Dr. ‌Divya Kumar |Clinical| Best Researcher Award

Dr at McLean Hospital, United States

Divya Kumar is a dedicated clinical psychologist with a focus on affective disorders and behavioral interventions. Currently completing a Post-Doctoral Fellowship at McLean Hospital/Harvard Medical School, Divya’s research and clinical experiences span various settings, including academic institutions and healthcare facilities. With expertise in positive affect dysregulation and depression treatment, Divya has authored multiple peer-reviewed publications and presented at national conferences. Their commitment to teaching and mentorship is evident through roles as an instructor and teaching assistant. Divya’s comprehensive training and contributions to the field make them a valuable asset in clinical research and practice.

Profile

 

📚Education 

McLean Hospital/Harvard Medical School Belmont, MA Post-Doctoral Fellowship, Clinical Psychology July 2023 – Present Pre-Doctoral Intern, Clinical Psychology July 2022 – June 2023 Southern Methodist University Dallas, TX Doctoral Candidate, Clinical Psychology July 2023 Advisor: Alicia E. Meuret, Ph.D. Dissertation: A randomized controlled trial of brief behavioral activation plus savoring for positive emotion dysregulation in university students Master of Arts, Clinical Psychology August 2020 Advisor: Alicia E. Meuret, Ph.D. Thesis: Walking on the bright side: Associations between depression, affect, and gait Washington University in St. Louis St. Louis, MO Bachelor of Arts, Philosophy-Neuroscience-Psychology December 2014

Honours and awards 🏆

🏆 2024 Career Development Leadership Program Anxiety and Depression Association of America🎓 2017 – 2023 University Ph.D. Fellowship Award Southern Methodist University🏅 2022 Virginia Roswell Student Dissertation Award Association of Behavioral and Cognitive Therapies🔬 2019 President Partner’s Grant Southern Methodist University (CO-I: Alicia Meuret)🎖️ 2019 Honorable Mention for Graduate Research Fellowship Program National Science Foundation🥇 2019 Graduate Student Research Day Award Dedman College, Southern Methodist University

manuscripts in peer reviewed journals

Kumar, D., Corner, S., Kim, R., Meuret, A. (2024). A randomized controlled trial of brief behavioral activation plus savoring for positive affect dysregulation in university students. Behaviour Research and Therapy, 104525. Alvi, T., Kumar, D., Tabak, B. (2022). Social anxiety and behavioral assessments of social cognition: A systematic review. Journal of Affective Disorders, 311, 17-30. Kumar, D., Villarreal, D. J., Meuret, A. E. (2021). Walking on the bright side: Relations between depression, affect, and gait. PLoS one, 16(12), e0260893. Kumar, D., Tully, L.M., Iosif, A.M., Nye, K.E., Zakskorn, L.N., Zia, A., Niendam, T.A. (2018). A mobile health platform for clinical monitoring in early psychosis: implementation in community-based outpatient early psychosis care. Journal of Medical Internet Research Mental Health, 5(1): e15. Niendam, T.A., Tully, L.M., Iosif, A.M., Kumar, D., Burch, K., Denton, J., Zakskorn, L., Fedechko, T., Pierce, K. (2018). Enhancing early psychosis treatment using smartphone technology Part I: Feasibility and validity. Journal of Psychiatric Research, 96, 239-246.

Clinical Experience 🏥

Behavioral Health Partial Hospitalization Program, McLean Hospital Belmont, MA Psychology Intern | July 2022 – July 2023As a psychology intern, I provided brief intervention for patients in the partial hospital program, drawing skills from CBT, ACT, and DBT. Additionally, I led and co-led skills-based groups on empirically supported therapies weekly. Moreover, I provided individual ERP therapy through the McLean Obsessive Compulsive Disorder Institute as part of a 3-month rotation and individual psychotherapy through the McLean OnTrack Early Psychosis Clinic. 🩺Treatment for Affective Dimensions Study, Dallas, TX Study Therapist | August 2018 – June 2022In this role, I provided psychotherapy related to increasing positive affect through behavioral activation, positive cognitive strategies, and mindfulness practices. I also offered psychotherapy related to decreasing negative affect through inhibitory learning model exposures, cognitive restructuring, and respiratory biofeedback. Furthermore, I conducted structured diagnostic evaluations (SCID-5) for study intake. 🧠SMU Psychology Clinic, Dallas, TX
Advanced Practicum Student | June 2021 – June 2022At the SMU Psychology Clinic, I provided structured diagnostic interviews and individual psychotherapy via telehealth to adult clients in Dallas using empirically-supported treatments such as CBT, ACT, and CPT. Additionally, I conducted symptom-based evaluations of trauma in collaboration with the Human Rights Initiative of Dallas for individuals seeking legal citizenship through the U-VISA program and Violence Against Women Act. 💬Behavioral Activation plus Savoring Study, Dallas, TX
Principal Investigator/Study Therapist | July 2021 – June 2022In this position, I served as the principal study therapist, providing two sessions of brief behavioral activation plus savoring therapy for university students with low positive affect. I also created therapy manuals and homework assignments for a randomized controlled trial and trained master’s-level graduate students in delivering manualized treatment. 📚Veteran’s Association North Texas Health Care System, Dallas, TX Practicum Student | August 2020 – June 2021During my time here, I provided individual psychotherapy via Telehealth utilizing Acceptance and Commitment Therapy to Veterans for symptoms relating to depression, anxiety, and physical health. Additionally, I engaged in individual supervision to enhance competency in providing gender-affirming care. 🔍

Additional Clinical Training Experience and Workshops 🎓

In addition to my clinical experience, I’ve undertaken various training sessions and workshops to enhance my skills and knowledge in the field of psychology:

Positive Affect Treatment Training 🌟Inhibitory Exposure (Negative Affect Treatment Training) 🛑Psychological Assessment Series Training: Millon Multiaxial Clinical Inventory 📝Psychological Assessment Series Training: Personality Assessment Inventory 🧠Comprehensive Behavioral Intervention for Tics 💭Treatment for Affective Disorders 🌈Capnometry-Assisted Respiratory Training 💨Cognitive Processing Therapy for Post-Traumatic Stress Disorder 🧠Integrated Psychosis Assessment Training 🔄Structured Clinical Interview for DSM-5 (SCID-5) Training 💬Training in Applied Behavior Analysis for Children with Autism 🧩

 

Publications Top Notes 📝

 

  1. Enhancing Early Psychosis Treatment Using Smartphone Technology: A Longitudinal Feasibility and Validity Study
    • Journal: Journal of Psychiatric Research, 2018
    • Citations: 117
    • Authors: T.A. Niendam, L.M. Tully, A.M. Iosif, D. Kumar, K.E. Nye, J.C. Denton, …

 

  1. A Mobile Health Platform for Clinical Monitoring in Early Psychosis: Implementation in Community-based Outpatient Early Psychosis Care
    • Journal: JMIR Mental Health, 2018
    • Citations: 75
    • Authors: D. Kumar, L.M. Tully, A.M. Iosif, L.N. Zakskorn, K.E. Nye, A. Zia, T.A. Niendam

 

  1. Social Anxiety and Behavioral Assessments of Social Cognition: A Systematic Review
    • Journal: Journal of Affective Disorders, 2022
    • Citations: 23
    • Authors: T. Alvi, D. Kumar, B.A. Tabak

 

  1. Walking on the Bright Side: Associations Between Affect, Depression, and Gait
    • Journal: PLOS One, 2021
    • Citations: 7
    • Authors: D. Kumar, D.J. Villarreal, A.E. Meuret

 

  1. A Randomized Controlled Trial of Brief Behavioral Activation Plus Savoring for Positive Affect Dysregulation in University Students
    • Journal: Behaviour Research and Therapy, 2024
    • Authors: D. Kumar, S. Corner, R. Kim, A. Meuret